Filter
295
Filtered Results: 295
Text search:
Lymphatic
filariasis
Featured
Recommendations
29
New Publications
85
Language
Document type
No document type
132
Studies & Reports
75
Guidelines
33
Strategic & Response Plan
28
Manuals
12
Videos
4
Training Material
3
Infographics
2
Fact sheets
2
Brochures
1
Dashboards/Maps
1
Resource Platforms
1
Online Courses
1
Countries / Regions
Global
44
Ethiopia
12
India
12
Africa
10
Uganda
9
Nepal
8
Kenya
8
Sierra Leone
8
Liberia
8
Ghana
6
Malawi
6
Latin America and the Carribbean
6
Bangladesh
5
Zambia
5
South Sudan
5
Mozambique
4
Tanzania
4
South–East Asia Region
4
Indonesia
4
Burkina Faso
3
Saudi Arabia
3
Sudan
3
Yemen
3
Myanmar / Burma
3
Rwanda
2
Cameroon
2
Syria
2
Iran
2
Philippines
2
Asia
2
Jordan
2
Congo, Democratic Republic of
2
Lebanon
2
Djibouti
2
Egypt
2
Botswana
2
Iraq
2
Somalia
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Nigeria
1
Albania
1
Laos
1
Afghanistan
1
Zimbabwe
1
Morocco
1
Qatar
1
Haiti
1
Cambodia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
East and Southern Africa
1
Brazil
1
Greece
1
Palestine
1
Georgia
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
122
Clinical Guidelines
39
Public Health
27
Key Resources
10
Capacity Building
4
Pharmacy & Technologies
3
Women & Child Health
2
Toolboxes
NTDs
101
Rapid Response
11
Planetary Health
9
Pharmacy
4
NCDs
4
Caregiver
3
Global Health Education
3
Mental Health
2
HIV
2
Cholera
2
Ebola
2
COVID-19
2
TB
1
Disability
1
Social Ethics
1
Conflict
1
Zika
1
Polio
1
AMR
1
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Analysis of microfilaria prevalence data from 430 communities
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a...
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
The South-East Asia regional programme to eliminate lymphatic filariasis (LF) was launched in 2000. This study presents the progress and impact of the programme in the region.
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
Effective monitoring, epidemiological assessment and evaluation are necessary to achieve the aim of interrupting LF transmission. This manual is designed to ensure that national elimination programmes have available the best information on methodologies and procedures for monitoring MDA, appropriate...
The Alere Filariaisis Test Strip (FTS) is a diagnostic test used to detect filarial antigens for lymphatic filariasis. This training video was developed by ENVISION in collaboration with the US Centers for Disease Control and Prevention, with funding provided by the US Agency for International Deve...
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
